NovaBridge Biosciences
NBP
$3.89
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.83M | -- | -- | -- | -20.49M |
| Total Depreciation and Amortization | 216.00K | -- | -- | -- | 196.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.46M | -- | -- | -- | 10.73M |
| Change in Net Operating Assets | 6.99M | -- | -- | -- | 17.99M |
| Cash from Operations | 1.84M | -- | -- | -- | 8.42M |
| Capital Expenditure | 0.00 | -- | -- | -- | -1.00K |
| Sale of Property, Plant, and Equipment | 0.00 | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -- | -- | -- | -81.65M |
| Cash from Investing | 0.00 | -- | -- | -- | -81.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.71M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -966.00K | -- | -- | -- | -- |
| Cash from Financing | 60.75M | -- | -- | -- | 0.00 |
| Foreign Exchange rate Adjustments | 73.00K | -- | -- | -- | 599.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.66M | -- | -- | -- | -72.63M |